GREB1 and breast carcinoma: Using the same Oncomine research platform, microarray data obtained from 2321 patients of human breast cancer patients (1651 ER-positive, 670 ER-negative) through 15 studies were also evaluated for the relationship between GREB1 expressions and other clinical parameters.